Drug Shortage Report for DAUNORUBICIN HYDROCHLORIDE INJECTION
| Report ID | 271038 |
| Drug Identification Number | 02539209 |
| Brand name | DAUNORUBICIN HYDROCHLORIDE INJECTION |
| Common or Proper name | DAUNORUBICIN HYDROCHLORIDE INJECTION |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DAUNORUBICIN |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 4mL |
| ATC code | L01DB |
| ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-10-31 |
| Estimated end date | 2026-03-16 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-11-04 | French | Compare |
| v1 | 2025-11-04 | English | Compare |
Showing 1 to 2 of 2